Is selling semaglutide illegal — and what does UK law actually say?

You saw a listing. Here is what the law says about it

Say you are scrolling on a Monday morning (payday week, a new month starting) and an advert appears offering Wegovy pens delivered within days, no doctor involved. It feels like a consumer transaction. Under UK law, it is not. Semaglutide is classified as a Prescription-Only Medicine under the Human Medicines Regulations 2012. That classification means a lawful supply requires two things to happen in sequence: a registered prescriber must assess the patient and issue a prescription, and a GPhC-registered pharmacy must dispense against it. Neither step is optional.

A seller who bypasses either step (whether they are operating a website, a social media account, or a physical premises) is committing a criminal offence. The offence sits under Part 14 of those regulations and can result in prosecution, unlimited fines, and imprisonment. This applies regardless of whether the product being sold is genuine or counterfeit; the act of selling a POM outside the authorised chain is itself unlawful. If you want to understand whether semaglutide is illegal and exactly where the law draws the line, our dedicated page sets out the detail clearly. You can also read more about the broader legal picture on our page covering whether semaglutide is legal in the UK.

The MHRA is clear on this. Their published guidance on GLP-1 medicines for weight loss states these are medicines that require clinical assessment, not consumer products. Selling them as if they were the latter is what the regulations exist to prevent.

Who is actually allowed to sell semaglutide in the UK

Lawful supply has a short list of requirements. The pharmacy must be registered with the General Pharmaceutical Council, you can check any pharmacy's registration status directly on the GPhC online register. The prescriber issuing the prescription must hold a valid registration with their relevant regulator (the GMC, GPhC as an Independent Prescriber, or the NMC for nurse prescribers). The medicine itself must enter the UK through the licensed supply chain, sourced from authorised distributors of the originator manufacturer.

For Wegovy specifically, that means Novo Nordisk's authorised UK supply network. A pharmacy that cannot confirm those supply-chain relationships (or that declines to) is a concern worth acting on. At nume, sorry, at nume, our GPhC premises registration number is 9012878, verifiable at the GPhC register, and every consultation is personally reviewed by a GPhC-registered Independent Prescriber before any prescription is issued.

It is also worth knowing what semaglutide is licensed for in the UK. Wegovy is licensed for weight management; Ozempic is the same molecule but licensed for type 2 diabetes. Neither is licensed for casual or cosmetic use. The MHRA has been explicit on this point. Our overview of semaglutide in the UK covers the licensing distinction in full.

What enforcement looks like, and why the risk to buyers is real

The MHRA's enforcement activity has been substantial. In 2025 alone, around 20 million doses of illegally traded weight-loss medicines with an estimated street value of approximately £45 million were seized. The regulator also conducted the first raid on an illicit UK manufacturing site producing counterfeit tirzepatide pens, located in Northampton. These are not obscure statistics, they represent the scale of an illegal market that has grown directly alongside demand for GLP-1 medicines.

The risk to the person buying from these channels is not hypothetical. The MHRA's October 2023 warning (reported on the Yellow Card reporting site, where you can also report suspect sellers) documented counterfeit pens containing insulin rather than semaglutide. Insulin injected at the wrong dose, without any clinical supervision, can cause life-threatening hypoglycaemia. The product looked right. The pen was wrong.

There is also no clinical oversight in an illegal sale. No one has checked your medical history, your other medications, your blood pressure, or whether semaglutide is appropriate for you. For a medicine with a known side-effect profile that includes pancreatitis, gallbladder problems, and interactions with oral contraceptives, that gap is not a minor inconvenience. Our page on Wegovy in the UK covers the full clinical picture, including eligibility and what a proper assessment involves.

Red flags, and what a legitimate route looks like instead

Some signals are straightforward. A seller offering semaglutide without a prescription is operating illegally, full stop. A price dramatically below what regulated pharmacies charge, a seller who cannot be found on the GPhC register, no clinical assessment of any kind, payment via untraceable methods: each is a reason to walk away, and collectively they are a clear pattern. The question of whether it is illegal to sell semaglutide and the question of whether a particular listing is legitimate are often the same question answered from different angles.

A legitimate route looks like this: a free consultation with a regulated service, a same-day review by a named prescriber, ID and weight verified, a prescription issued only if you are clinically suitable, and the medicine dispensed from a GPhC-registered pharmacy through the authorised supply chain. That process exists because semaglutide requires it, not as a commercial inconvenience but as the clinical minimum. You can explore what that looks like in practice on our guide to obtaining Wegovy through a legitimate UK route, or browse our weight-loss treatment options more broadly.

If you are clinically suitable and ready to speak to a prescriber, start your free consultation with our prescribers and have your questions answered properly.